Mild Cognitive Impairment Diagnosis and Care Algorithms and the Role of Digital Interventions: Expert Consensus轻度认知障碍诊断与护理算法以及数字干预的作用：专家共识CNS Neuroscience & TherapeuticsIF52026-09-030OAAI
Strategies for the use of Ginkgo biloba extract, EGb 761(R), in the treatment and management of mild cognitive impairment in Asia: Expert consensusCNS NEUROSCIENCE & THERAPEUTICSIF52020-12-2221OAAI
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®CNS NEUROSCIENCE & THERAPEUTICSIF52019-01-15100OAAI
Ginkgo biloba extract EGb 761® alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trialsCLINICAL INTERVENTIONS IN AGINGIF3.72018-06-0134OAAI
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportBMC MEDICINEIF8.32017-05-2488OAAI
Therapeutic efficacy of the Ginkgo special extract EGb761 within the framework of the mitochondrial cascade hypothesis of Alzheimer's diseaseWORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82017-05-0235OAAI
Effects of Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: review of recently completed randomised, controlled trialsINTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICEIF2.72013-08-2742PREAI
Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementiaINTERNATIONAL PSYCHOGERIATRICSIF4.32012-11-3010PREAI
Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical studyINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82012-04-115PREAI
Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled TrialPHARMACOPSYCHIATRYIF2.22011-11-1597OAAI
Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practiceALZHEIMERS RESEARCH & THERAPYIF7.62011-09-1422OAAI
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trialNEUROPSYCHIATRIC DISEASE AND TREATMENTIF2.92011-04-0153OAAI
Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's diseaseINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82011-03-0818PREAI
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's disease and other dementiasWORLD JOURNAL OF BIOLOGICAL PSYCHIATRYIF3.82011-02-0270PREAI
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trialINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82010-12-0793PREAI
Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trialJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22010-12-0121PREAI
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?ALZHEIMERS RESEARCH & THERAPYIF7.62010-08-26103OAAI
World psychiatric association section of old age psychiatry consensus statement on ethics and capacity in older people with mental disordersINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82009-11-1320OAAI
Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patientsALZHEIMERS & DEMENTIAIF11.12009-09-0138PREAI
Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patientsALZHEIMERS & DEMENTIAIF11.12009-09-0123PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向